Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
17301 W Colfax Ave, Golden, Colorado, 80401, United States
The BioIntelliSense Data-as-a-Service (DaaS) platform and FDA-cleared BioSticker™ on-body sensor are bringing medical grade monitoring and management to the home for scalable remote care.
BioIntelliSense, Inc. a continuous health monitoring and clinical intelligence company, today announced that it has been named Best of Innovation as a CES® 2021 Innovation Awards Honoree for the BioButton™ medical-grade wearable device and data services. The “Best of Innovation” award is given to only the highest-rated product in each category and is not assured for any category in any year unless the total scores for a product exceed an exceptional threshold.
AlertWatch AC, an FDA-cleared solution, revolutionizes ICU care by aggregating diverse patient data into a centralized dashboard. Its advanced analytics and alerts enable proactive interventions, …
Posted Advanced Alternative Payment Model (APM) Advanced Analytics Remote Patient Monitoring
Last Updated
The BioButton is a scalable and cost-effective solution for health screening, COVID-19 symptom monitoring and remote patient monitoring. The BioButton wearable medical-grade monitoring and BioMobile …
Posted Remote Patient Monitoring
Last Updated
AlertWatch, a patient monitoring technology with FDA clearance and solid clinical data, is acquired by BioIntelliSense, Inc. For more effective, proactive healthcare decisions, AlertWatch offers …
Posted Oct 20, 2022 Digital Health
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 23, 2024 at 3:40am